203 related articles for article (PubMed ID: 28762094)
1. SPECT but not PET remains as the working horse of the state of the art nuclear cardiac imaging laboratory: Con.
Saraste A; Knuuti J
J Nucl Cardiol; 2018 Feb; 25(1):198-202. PubMed ID: 28762094
[No Abstract] [Full Text] [Related]
2. SPECT: Workhorse of state of the art nuclear cardiology.
Henzlova MJ
J Nucl Cardiol; 2018 Feb; 25(1):195-197. PubMed ID: 28730415
[No Abstract] [Full Text] [Related]
3. Quantification in SPECT cardiac imaging.
Iida H; Hayashi T; Eberl S; Saji H
J Nucl Med; 2003 Jan; 44(1):40-2. PubMed ID: 12515875
[No Abstract] [Full Text] [Related]
4. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis.
Jaarsma C; Leiner T; Bekkers SC; Crijns HJ; Wildberger JE; Nagel E; Nelemans PJ; Schalla S
J Am Coll Cardiol; 2012 May; 59(19):1719-28. PubMed ID: 22554604
[TBL] [Abstract][Full Text] [Related]
5. Cardiac positron emission tomography imaging.
Machac J
Semin Nucl Med; 2005 Jan; 35(1):17-36. PubMed ID: 15645392
[TBL] [Abstract][Full Text] [Related]
6. Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel
Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
Trends Cardiovasc Med; 2020 Jan; 30(1):11-19. PubMed ID: 30824163
[TBL] [Abstract][Full Text] [Related]
7. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.
Berman DS; Maddahi J; Tamarappoo BK; Czernin J; Taillefer R; Udelson JE; Gibson CM; Devine M; Lazewatsky J; Bhat G; Washburn D
J Am Coll Cardiol; 2013 Jan; 61(4):469-477. PubMed ID: 23265345
[TBL] [Abstract][Full Text] [Related]
8. Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.
Kazakauskaitė E; Žaliaduonytė-Pekšienė D; Rumbinaitė E; Keršulis J; Kulakienė I; Jurkevičius R
Medicina (Kaunas); 2018 Jul; 54(3):. PubMed ID: 30344278
[TBL] [Abstract][Full Text] [Related]
9. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
[TBL] [Abstract][Full Text] [Related]
10. Nuclear investigative techniques and their interpretation in the heart and vascular disease.
Ora M; Gambhir S
Ann Card Anaesth; 2020; 23(3):262-271. PubMed ID: 32687080
[TBL] [Abstract][Full Text] [Related]
11. Development of radiolabeled compounds for myocardial perfusion imaging.
Lin X; Zhang J; Wang X; Tang Z; Zhang X; Lu J
Curr Pharm Des; 2012; 18(8):1041-57. PubMed ID: 22272824
[TBL] [Abstract][Full Text] [Related]
12. Myocardial perfusion quantitation with PET: time to do our homework.
Fricke E
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1592-3. PubMed ID: 19526235
[No Abstract] [Full Text] [Related]
13. SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability.
Beller GA; Heede RC
J Cardiovasc Transl Res; 2011 Aug; 4(4):416-24. PubMed ID: 21732226
[TBL] [Abstract][Full Text] [Related]
14. Highlights from the Updated Joint ASNC/SNMMI PET Myocardial Perfusion and Metabolism Clinical Imaging Guidelines.
Dilsizian V
J Nucl Med; 2016 Sep; 57(9):1327-8. PubMed ID: 27199358
[No Abstract] [Full Text] [Related]
15. Methodology for quantifying absolute myocardial perfusion with PET and SPECT.
Lodge MA; Bengel FM
Curr Cardiol Rep; 2007 Apr; 9(2):121-8. PubMed ID: 17430679
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis.
Parker MW; Iskandar A; Limone B; Perugini A; Kim H; Jones C; Calamari B; Coleman CI; Heller GV
Circ Cardiovasc Imaging; 2012 Nov; 5(6):700-7. PubMed ID: 23051888
[TBL] [Abstract][Full Text] [Related]
17. Positron-emitting myocardial blood flow tracers and clinical potential.
Schindler TH
Prog Cardiovasc Dis; 2015; 57(6):588-606. PubMed ID: 25637500
[TBL] [Abstract][Full Text] [Related]
18. PET-Based Imaging of Ischemic Heart Disease.
Chen K; Miller EJ; Sadeghi MM
PET Clin; 2019 Apr; 14(2):211-221. PubMed ID: 30826019
[TBL] [Abstract][Full Text] [Related]
19. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
